CAS 1638851-44-1

Fórmula: C22H25ClO7

InChI: InChI=1S/C22H25ClO7/c1-3-28-16-7-4-13(5-8-16)10-14-11-15(6-9-17(14)23)22-20(26)18(24)19(25)21(27-2,30-22)12-29-22/h4-9,11,18-20,24-26H,3,10,12H2,1-2H3/t18-,19-,20+,21-,22-/m0/s1

Chave InChI: UFWQAQJFRMQRFR-CUUWFGFTSA-N

SMILES: CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)OC)O)O)O)Cl

HSK0935

CAS: 1638851-44-1

HSK0935

Fórmula: C₂₂H₂₅ClO₇

Pureza: 96.63%

Peso molecular: 436.88

Ref: 54-OR1138107

HSK0935

CAS: 1638851-44-1

Fórmula: C₂₂H₂₅ClO₇

Pureza: 96.63%

Peso molecular: 436.8827

Ref: IN-DA01V3OY

HSK0935

CAS: 1638851-44-1

HSK0935 is a highly selective and orally available SGLT2 inhibitor (IC50: 1.3 nM). It has antihyperglycemic activities.

Fórmula: C₂₂H₂₅ClO₇

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 436.883

Ref: TM-T15505

1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-methoxy-β-L-idopyranose

CAS: 1638851-44-1

1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-methoxy-β-L-idopyranose is a potent and selective activator of the Kv1.2 potassium channel. It has been shown to increase the membrane potential in rat sympathetic neurons and to inhibit voltage sensitive sodium channels in rat hippocampal neurons. This compound also activates K+ currents in a concentration dependent manner in human embryonic kidney cells, suggesting that it may have a therapeutic effect on disorders such as epilepsy or Alzheimer's disease.

Fórmula: C₂₂H₂₅ClO₇

Pureza: Min. 95%

Peso molecular: 436.9 g/mol

Ref: 3D-NQC85144